Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays
about
Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.High tumor budding stratifies breast cancer with metastatic properties.Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast CancersEvaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer.Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis.Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.Dermatofibrosarcoma protuberans of the breast: A case report.Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume.FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy.Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer.Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.
P2860
Q30491493-66D1C1D9-FF62-4E53-9764-20908366455AQ35203546-EB94A5D1-1625-4F96-AF51-D2FC4B037AF3Q35949292-DD913B87-8230-414B-8E93-CC6851CF46FAQ35949311-330B4E2B-3D07-4812-B188-C6C8069FB34CQ36281258-4AADA7A6-F5E0-4A66-8637-44C614F149E5Q37220650-8E95BB02-FBB3-43BD-872E-1E855DCDF5C8Q38597055-FE7FF210-6019-407E-BA67-08B647B5ADC9Q40045274-AA179B1A-0B5D-457C-85CD-861973E7E243Q40305198-0E7FC6F7-63CA-41BF-977D-398C897DD615Q40979604-7D66BA16-A4D2-4657-8EB9-C44F0EBB76FAQ48719284-83F468C5-BDF9-4D3D-9117-BB9FA67C167CQ51168093-1B3C7F1D-E422-404C-B242-83A842A8AC9FQ51549817-BDC428CA-0F34-47E6-A52D-4034175DAC56Q52680900-16E1D5BB-6BFC-4198-B666-956A381C435EQ55284921-71F0664B-9F9D-41AA-BE11-88B5BA1BE256Q55431092-897F2AF1-8EDA-4115-86B4-136BACE40072
P2860
Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@ast
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@en
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@nl
type
label
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@ast
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@en
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@nl
prefLabel
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@ast
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@en
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@nl
P2093
P2860
P1433
P1476
Evaluation of Ki67 expression ...... iopsies and tissue microarrays
@en
P2093
Gøril Knutsvik
Ingunn M Stefansson
Jarle Arnes
Johan Eide
Karin Collett
P2860
P304
P356
10.1371/JOURNAL.PONE.0112121
P407
P577
2014-11-06T00:00:00Z